首页 | 本学科首页   官方微博 | 高级检索  
检索        

原发性肝癌经肝动脉化疗栓塞术后共刺激分子4-1BB(CD137)配体的变化和意义
引用本文:刘谨文,易继林,黄亚非.原发性肝癌经肝动脉化疗栓塞术后共刺激分子4-1BB(CD137)配体的变化和意义[J].临床外科杂志,2005,13(4):228-230.
作者姓名:刘谨文  易继林  黄亚非
作者单位:430030,武汉,华中科技大学同济医学院附属同济医院普外科;华中科技大学同济医学院免疫教研室
摘    要:目的 探讨原发性肝癌经肝动脉化疗栓塞(TACE)前后肝癌细胞的共刺激分子4 -1BB(CD13 7)的配体(4- 1BBL)的变化及意义。方法 选取经TACE治疗后二期手术切除的原发性肝癌患者标本14例(TACE组)和未经TACE单纯手术切除的原发性肝癌患者标本2 1例(单纯手术组) ,应用免疫组织化学方法和RT -PCR方法检测肝癌细胞的4 -1BBL及4- 1BBLmRNA表达情况。结果 TACE组肝癌细胞中4 -1BBL和4- 1BBLmRNA的表达明显低于单纯手术组。结论 TACE后肝癌细胞中4 -1BBL的表达下调会影响机体的抗肿瘤免疫反应,并可能是TACE治疗原发性肝癌难以根治并易复发、转移的原因之一。

关 键 词:原发性肝癌  化疗栓塞  4-1BBL
文章编号:1005-6483(2005)04-0228-03
修稿时间:2005年2月5日

The changes and significance of 4-1BB(CD137) ligant in hepatocellular carcinom fter transcatheter arterial chemoembolization
LIU Jin-wen,YI Ji-lin,HUANG Ya-fei.The changes and significance of 4-1BB(CD137) ligant in hepatocellular carcinom fter transcatheter arterial chemoembolization[J].Journal of Clinical Surgery,2005,13(4):228-230.
Authors:LIU Jin-wen  YI Ji-lin  HUANG Ya-fei
Abstract:Objective To investigate the expression of 4-1BB(CD137) ligant(4-1BBL) in hepatocellular carcinoma(HCC) that treated and untreated by transcatheter arterial chemoembolization(TACE). Methods The expression of 4-1BBL and 4-1BBLmRNA in HCC were measured by immunohistochemistry method and RT-PCR technique. The surgical specimen were obtained from 14 HCC patients who had been treated by TACE and 21 patients who without TACE. Results:The expression of 4-1BBL in HCC who without TACE was lower than that had been treated by TACE significantly.Conclusion The expression of 4-1BBL in HCC will be down regulated after TACE. This would influence the anti-tumor immunity effect, which would be one of the reasons of that why HCC is difficultly healed and recurred ?metastasized easily after TACE.
Keywords:hepatocellular carcinoma  chemoembolization  4-1BB  ligant
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号